Semax is a synthetic heptapeptide derived from the sequence of the N-terminal fragment of adrenocorticotropic hormone (ACTH 4-10). It has been investigated in laboratory research involving neurotrophic signaling, BDNF expression, cellular signaling, and neurobiology. Helix Bio offers Semax as a research-use-only peptide for qualified laboratory and non-clinical research. It is not intended for human or veterinary use, ingestion, injection, diagnosis, treatment, or prevention of disease.
HPLC certified
Independent analysis
Highest standard
Full traceability
Semax is a synthetic seven-amino-acid peptide commonly described by the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Scientific literature identifies it as an analog of the ACTH(4-10) fragment.
For research purposes, Semax is primarily relevant to investigations of peptide signaling and neurobiology. Published studies have examined its relationship with neurotrophic factors, including brain-derived neurotrophic factor (BDNF), as well as Trk receptor-related signaling.
Major content areas include:
Semax is a heptapeptide, meaning it consists of seven amino-acid residues. Its commonly reported sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The molecule is structurally related to the ACTH(4-10) fragment, while the addition of the Pro-Gly-Pro portion distinguishes Semax as a modified peptide rather than native ACTH(4-10). This structural relationship makes Semax useful for research into how relatively small peptide modifications can influence molecular interactions and downstream biological signaling.
One of the most frequently studied aspects of Semax is its relationship with brain-derived neurotrophic factor (BDNF). In a published experimental study, researchers reported specific Semax binding in rat basal forebrain tissue and observed changes in BDNF protein levels following experimental administration. Another study examined Semax in rat hippocampal tissue and reported changes involving BDNF and TrkB expression and phosphorylation. These findings are relevant to basic research into neurotrophic signaling, but they do not establish that Semax produces equivalent effects in humans.
There is no single, fully established mechanism that explains every observed experimental effect of Semax. Research has investigated several molecular features, including BDNF expression, TrkB-related signaling, neurotrophin gene expression, specific peptide binding, cellular signaling responses, and brain-region-specific experimental effects. Because much of the mechanistic literature involves animal or cellular models, findings should be interpreted within the limitations of the specific experimental system.
Neurotrophic signaling is an important area of Semax research. BDNF is a neurotrophin involved in neuronal signaling and synaptic plasticity, and researchers have investigated whether Semax exposure changes BDNF-related molecular pathways in experimental models. This makes Semax a useful research subject for experiments focused on neurotrophin expression, BDNF signaling, Trk receptor pathways, gene-expression responses, peptide-mediated cellular signaling, and brain-region-specific molecular responses.
Semax and N-Acetyl Semax are related peptide research compounds, but they should not be treated as identical materials. The N-acetyl modification changes the chemical structure of the peptide. Researchers interested in comparing these compounds should consider molecular structure, chemical modification, analytical identity, purity profile, experimental model, and research objective.
Semax is relevant to research programs investigating the relationship between peptide structure and neurotrophic signaling. For laboratories evaluating a Semax research peptide supplier, analytical documentation is an important consideration — researchers should be able to establish what compound they received, understand the reported purity, and associate testing results with the relevant batch.
Helix Bio's quality program includes reversed-phase HPLC purity testing, LC-MS identity/molecular-weight confirmation, and batch-specific analytical documentation, with chromatograms and analytical information supplied with orders.
Semax is not intended for human consumption, injection, self-administration, veterinary use, or medical treatment.
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Knowledge Base
Cyclic peptides resist protease degradation and reach undruggable targets. Learn how peptide cyclization works and why stability improves. Explore the research.
How continuous flow, automation, enzymatic routes and AI are changing peptide synthesis technology, and what it means for research peptide purity and supply.
AI now designs peptides from scratch. How AlphaFold 3, RFdiffusion and protein language models reshaped peptide discovery in 2026 — research use only.
